Chinese Markets for Respiratory DrugsAsia Market Information & Development CompanySeptember 1, 2009 176 Pages - SKU: ASM2435542 |
| Countries covered: China China's demand for Respiratory Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled. |
More China Respiratory/Pulmonary Reports
Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 by
GlobalData
Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Summary GlobalData’s new report, “Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, ...
China Asthmatic Prescription Drugs Sales Data 2006-2010 by
Draco Healthcare Consulting LLC
The series of China Prescription Drug (CPD) sales reports have systemically analyzed Chinese prescription drug market, according to different therapeutic areas. All market estimates ...
Epidemiology: COPD in China by
Datamonitor
Introduction Datamonitor's research shows that out to 2020, COPD will continue to be a major threat to Chinese adults. The number of prevalent cases of COPD ...
Research Report on Industry of Oral Antibiotics for Children in China, 2011-2012 by
China Research and Intelligence Co., Ltd.
The prevalence rate of Chinese children aged 0-14 is 15%, and the proportion of sick children in total sick population is about 20%. About 85% ...
Chinese Markets for Pneumonia Treatment Drugs by
Asia Market Information & Development Company
China's demand for Pneumonia Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand ...
See all reports like this >>
More China Reports
D&B Country RiskLine Report: China by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
Country Report China February 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Country Report China January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
D&B Country Report: China by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Juice – China – a snapshot (2010) by
Mintel - Snapshots
Juice in China by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. The report covers packaged ...
See all reports like this >>
Related Markets
Respiratory/Pulmonary Reports
- Triple Analysis: Lung Cancer, Protein Kinase Inhibitors and Peptides
- Triple Analysis: Lung Cancer, Protein Kinase Inhibitors and Antibodies
- Triple Analysis: Lung Cancer, Angiogenesis and Protein Kinase Inhibitors
- Triple Analysis: Breast Cancer, Lung Cancer and Protein Kinase Inhibitors
- Viral Respiratory Tract Infection Global Clinical Trials Review, H1, 2012

